Results 251 to 260 of about 371,957 (300)
Some of the next articles are maybe not open access.
Annual Review of Microbiology, 1984
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
INTRODUCTION...... ..... 221 Vaccines in the Control of Virus Diseases .....
openaire +2 more sources
Seminars in Oncology, 2005
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
Recent advances in understanding tumor-specific immunity have introduced new excitement in the clinical development of vaccines for the treatment of cancer. A better understanding of basic immunologic principles has led to a variety of techniques for enhancing tumor-specific immunity through vaccination.
Philip M, Arlen +2 more
openaire +2 more sources
VacciTUTOR, 2021
Viral vector vaccines use harmless, non-replicating or replicating viruses to deliver genetic material for production of vaccine antigens into host cell cytoplasm. While viral vector vaccines may theoretically induce life-long immunity with low antigen concentrations, their attenuation, safety and spread to the community are of concern. Vaccines based
Valerie Oriol Mathieu +3 more
openaire +1 more source
Viral vector vaccines use harmless, non-replicating or replicating viruses to deliver genetic material for production of vaccine antigens into host cell cytoplasm. While viral vector vaccines may theoretically induce life-long immunity with low antigen concentrations, their attenuation, safety and spread to the community are of concern. Vaccines based
Valerie Oriol Mathieu +3 more
openaire +1 more source
2004
Tumor-associated antigens (TAAs) are by definition either weakly immunogenic or functionally nonimmunogenic. Vaccine strategies must be developed in which the presentation of these TAAs to the immune system results in far greater activation of T cells than is being achieved naturally in the host.
James L. Gulley +2 more
openaire +1 more source
Tumor-associated antigens (TAAs) are by definition either weakly immunogenic or functionally nonimmunogenic. Vaccine strategies must be developed in which the presentation of these TAAs to the immune system results in far greater activation of T cells than is being achieved naturally in the host.
James L. Gulley +2 more
openaire +1 more source
2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire +1 more source
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire +1 more source
2001
Update on antiviral DNA vaccine research (1998-2000) optimization strategies for DNA vaccines relative potency of cellular and humoral immune responses induced by DNA vaccination improving DNA vaccines targeting viral infection alphavirus vectors - applications for DNA vaccine production and gene expression plasmid DNA vaccines - investigation of ...
openaire +1 more source
Update on antiviral DNA vaccine research (1998-2000) optimization strategies for DNA vaccines relative potency of cellular and humoral immune responses induced by DNA vaccination improving DNA vaccines targeting viral infection alphavirus vectors - applications for DNA vaccine production and gene expression plasmid DNA vaccines - investigation of ...
openaire +1 more source
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Nature Reviews Drug Discovery, 2021Namit Chaudhary +2 more
exaly